208
Participants
Start Date
December 11, 2018
Primary Completion Date
August 9, 2021
Study Completion Date
September 9, 2021
elezanumab
solution for infusion
placebo
solution for infusion
Thomas Jefferson University /ID# 204281, Philadelphia
Duplicate_Parexel International /ID# 204273, Baltimore
Integrated Neurology Services, PLLC /ID# 204261, Alexandria
West Virginia Univ School Med /ID# 204292, Morgantown
University of Alabama at Birmingham - Main /ID# 204618, Birmingham
Advanced Neurosciences Institute /ID# 204557, Franklin
Tri-State Mountain Neurology /ID# 204252, Johnson City
Indiana Univ School Medicine /ID# 204891, Indianapolis
Michigan Institute for Neurological Disorders (MIND) /ID# 204194, Farmington Hills
Washington University-School of Medicine /ID# 204388, St Louis
Rowe Neurology Institute /ID# 204391, Lenexa
The NeuroMedical Center /ID# 204253, Baton Rouge
Oklahoma Med Res. Foundation /ID# 204389, Oklahoma City
Central Texas Neurology Consul /ID# 204268, Round Rock
Dr. Bhupesh Dihenia, MD, PA /ID# 207839, Lubbock
Advanced Neurosciences Research, LLC /ID# 204289, Fort Collins
St. Josephs Hospital and Med Center /ID# 204197, Phoenix
UC Irvine Health /ID# 205728, Irvine
Virginia Mason Medical Center /ID# 205440, Seattle
Sutter East Bay Medical Foundation-Jordon Research and Education Dev. Inst. /ID# 204249, Berkeley
The Research Center of Southern California /ID# 204269, Carlsbad
Vladimir Royter MD /ID# 204392, Hanford
Stanford MS Center /ID# 204283, Palo Alto
UC Davis Health-Neurological Surgery /ID# 204188, Sacramento
UCSF School of Medicine - Neurology /ID# 204251, San Francisco
University of Colorado School of Medicine /ID# 204250, Aurora
The University of Chicago Medical Center /ID# 205319, Chicago
Ochsner Medical Center /ID# 204189, New Orleans
International Neurorehabilitation Institute /ID# 213332, Lutherville
Pediatric Endocrine Associates /ID# 204279, Boston
Memorial Neurological Institute and Center for Multiple Sclerosis /ID# 206328, Owosso
Ridgeview Specialty Clinic Chaska - Neurology /ID# 204383, Chaska
The MS Center for Innovations in Care at Missouri Baptist Medical Center /ID# 205433, St Louis
Cleveland Clinic Lou Ruvo Cent /ID# 204745, Las Vegas
Providence Neurological Specialties - West /ID# 204248, Portland
KCA Neurology - Franklin /ID# 204208, Franklin
Neurology Consultants of Dallas - LBJ Fwy /ID# 204398, Dallas
UT HSC Multiple Sclerosis Research Group - Houston /ID# 206418, Houston
Evergreen Neuroscience Institute /ID# 204203, Kirkland
Swedish MS Center /ID# 204198, Seattle
University of Washington Medicine MS Center /ID# 205852, Seattle
Froedtert Memorial Lutheran Hospital /ID# 204202, Milwaukee
University of British Columbia - MS & NMO Clinical Trials Group, Djavad Mowafagh /ID# 204841, Vancouver
Duplicate_London Health Sciences Centre - University Hospital /ID# 204848, London
Ottawa Hospital Research Institute /ID# 204842, Ottawa
Unity Health Toronto - St. Michael's Hospital /ID# 206214, Toronto
Recherche Sepmus Inc. /ID# 212851, Greenfield Park
Centre Hospitalier de l'Universite de Montreal - CRCHUM /ID# 204844, Montreal
Montreal Neurological Institut /ID# 204843, Montreal
Lead Sponsor
AbbVie
INDUSTRY